These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6522447)

  • 1. [Pressure-course events in the tabletting of phenylbutazone].
    Wenzel U; Kala H
    Pharmazie; 1984 Oct; 39(10):693-4. PubMed ID: 6522447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on the dissolution behavior of a tablet formulation: effect of compression forces.
    Ibrahim HG
    J Pharm Sci; 1985 May; 74(5):575-7. PubMed ID: 4020638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the effect of the binding agent and compression pressure on the properties of granulates and tablets prepared by fluidization and pulverization].
    Salama AH; Kovács B; Gyarmathy M; Gyarmati L
    Acta Pharm Hung; 1976 Jan; 46(1):24-30. PubMed ID: 1258649
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the compression behaviour of spray-dried sulphathiazole (author's transl)].
    Kala H; Moldenhauer H; Giese R; Kedvessy G; Selmeczi B; Pintye-Hódi K
    Pharmazie; 1982 Feb; 37(2):129-31. PubMed ID: 7071118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The liberation of phenylbutazone from tablets].
    Miseta M; Hoang Hun Manh ; Pintye-Hódi K; Szabó-Révész P; Selmeczi B
    Pharmazie; 1988 Oct; 43(10):697-8. PubMed ID: 3212016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of die-wall instrumentation for research and development in tabletting.
    Doelker E; Massuelle D
    Eur J Pharm Biopharm; 2004 Sep; 58(2):427-44. PubMed ID: 15296965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimization of the composition of tablets of phenylbutazone and aminophenazone by means of trial planning].
    Welikowa E; Jonowa R; Jontschew C
    Pharmazie; 1977; 32(8-9):502-4. PubMed ID: 594116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of adjuvant ingredients and technology in the tabletting of hard-to-compress pharmaceuticals. I. Direct compression].
    Miseta M; Pintyéné-Hódi K; Szabóné-Révész P; Selmeczi B
    Acta Pharm Hung; 1986 May; 56(3):121-4. PubMed ID: 3739723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the study on phenylbutazone-sulfamides. I. -- Phenylbutazone-sulfanilamide and phenylbutazone-sulfathiazol associations (author's transl)].
    Jeanjean B; Alberola S; Rambaud J; Sabon F
    Ann Pharm Fr; 1979; 37(5-6):175-80. PubMed ID: 543592
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of Henderson equation for the determination of weakly acidic pharmaceutical compounds. Part 3: Determination of phenylbutazone.
    El-Fatatry HM; Sharafel-Deen MM; Amer MM
    Pharmazie; 1979; 34(3):155-7. PubMed ID: 450955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recording of pressure-path diagrams from an excentric press using piezoelectric measurement].
    Moldenhauer H; Hünerbein B; Kala H
    Pharmazie; 1972 Jun; 27(6):417-8. PubMed ID: 5082273
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of degradation products in a phenylbutazone tablet formulation.
    Matsui F; Robertson DL; Poirier MA; Lovering EG
    J Pharm Sci; 1980 Apr; 69(4):469-71. PubMed ID: 7373550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into segregation during tabletting.
    Lakio S; Siiriä S; Räikkönen H; Airaksinen S; Närvänen T; Antikainen O; Yliruusi J
    Int J Pharm; 2010 Sep; 397(1-2):19-26. PubMed ID: 20600718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case study of illicit preparation of antirheumatic analgesic with phenylbutazone as active ingredient.
    Thuan CE; Huat LB
    Med J Malaysia; 1989 Jun; 44(2):160-6. PubMed ID: 2626126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.
    Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N
    Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On some parameters for the investigation and evaluation of the deformation behaviour of powder mixtures during tabletting (author's transl)].
    Dinev P; Welikowa E
    Pharmazie; 1981; 36(1):37-40. PubMed ID: 7220584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
    Dave VS; Fahmy RM; Hoag SW
    Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated compaction of tablets on tablet properties and work of compaction using an instrumented laboratory tablet press.
    Gamlen MJ; Martini LG; Al Obaidy KG
    Drug Dev Ind Pharm; 2015 Jan; 41(1):163-9. PubMed ID: 24171692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrophotometric determination of dipyrone, phenylbutazone and oxyphenbutazone by their hydrolysis and Schiff base formation with 4-dimethylaminobenzaldehyde.
    Verma KK; Jain A; Patel N; Sanghi SK
    Farmaco Prat; 1987 Jul; 42(7):185-92. PubMed ID: 3622752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.